CONSOLIDATED STATEMENT OF CASH FLOWS (USD $)	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Cash flows from operating activities:
Net loss	$ (5,164,497)	$ (1,892,644)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	7,443	7,013
Amortization	143,383	70,588
Accretion of deferred financing costs	450,806
Provision for bad debt expense	150,000
Change in estimated fair value of derivative	(595,030)
Amortization of debt discount	657,307
Stock issued to founders		855
Fair value of stock issued for services	331,341	150,010
Stock based compensation	694,533	64,592
Accounts receivable	(293,065)	(369,301)
Inventory	(39,681)	(634,704)
Prepaid expenses and other current assets	(336,497)	(73,644)
Other assets	3,948	(957,283)
Accounts payable and accrued expenses	582,946	496,295
Other current liabilities		241
Net cash used in operating activities	(3,407,063)	3,137,982
Cash flows from investing activities:
Change in restricted cash	(51,761)	(81,000)
Purchase of property and equipment	(1,299)	(6,050)
Net cash used in investing activities	(53,060)	(87,050)
Cash flow from financing activities:
Proceeds from issuance in common stock		3,375,032
Proceeds from notes payable	4,009,000
Deferred financing costs paid	(354,704)
Repayments on notes payable	(172,000)
Proceeds from issuance of notes receivable		(150,000)
Net cash provided by financing activities	3,482,296	3,225,032
NET INCREASE (DECREASE) IN CASH	22,173
CASH - beginning of period	4,449
CASH - end of period	26,622
SUPPLEMENTAL DISCLOSURES
Interest paid in cash	58,758
Non-cash transactions:
Conversion of preferred stock to common stock	25,304
Conversion of notes payable and accrued interest to common stock	860,818
Warrants issued as deferred financing costs	418,042
Warrants issued as debt discount	$ 1,163,240